NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 839.85
+15.80 (1.92%)
At close: Jan 21, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 149.01 billion as of January 23, 2026. Its market cap has decreased by -36.44% in one year.
Market Cap
149.01B
Enterprise Value
119.62B
Revenue
43.90B
Ranking
n/a
PE Ratio
9.68
Stock Price
839.85
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 149.01B, an increase of 34,602.94%. That is a compound annual growth rate of 24.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 149.01B | -7.87% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 294.79B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.52B |
| Caplin Point Laboratories | 137.79B |
| Granules India | 134.12B |
| Rubicon Research | 109.30B |
| Sanofi India | 93.47B |
| CORONA Remedies | 92.12B |